Philippe Camus, M.D.

Dijon, France

Both apps are now back!

Back to drug

The Drug-Induced Respiratory Disease Website and App

Frequency - Incidence

Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases

Evidence level/grade

Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic

VIII.d

Fibrosing mediastinitis

May be complicated by pulmonary vein stenosis, pulmonary edema or pleural effusion

Publications

Saito N, Nadgir RN, Nakahira M, Takahashi M, Uchino A, Kimura F, Truong MT, Sakai O

Posttreatment CT and MR imaging in head and neck cancer: what the radiologist needs to know.

Radiographics : a review publication of the Radiological Society of North America, Inc 2012 Sep-Oct;32;1261-82; discussion 1282-4 — 2012 Sep-Oct — 1261-82; discussion 1282-4

Rossi SE, McAdams HP, Rosado-de-Christenson ML, Franks TJ, Galvin JR

Fibrosing mediastinitis.

Radiographics : a review publication of the Radiological Society of North America, Inc 2001 May-Jun;21;737-57 — 2001 May-Jun — 737-57

Dechambre St, Dorzee J, Fastrez J, Hanzen C, Van Houtte P, d'Odémont JP

Bronchial stenosis and sclerosing mediastinitis: an uncommon complication of external thoracic radiotherapy.

The European respiratory journal 1998 May;11;1188-90 — 1998 May — 1188-90

Morrone N, Gama e Silva Volpe VL, Dourado AM, Mitre F, Coletta EN

Bilateral pleural effusion due to mediastinal fibrosis induced by radiotherapy.

Chest 1993 Oct;104;1276-8 — 1993 Oct — 1276-8

Libshitz HI, Brosof AB, Southard ME

Radiographic appearance of the chest following extended field radiation therapy for Hodgkin's disease. A consideration of time-dose relationships.

Cancer 1973 Jul;32;206-15 — 1973 Jul — 206-15